Literature DB >> 17032891

Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality.

Kathleen A Cronin1, Angela B Mariotto, Lauren D Clarke, Eric J Feuer.   

Abstract

In estimating the impact of mammography and adjuvant treatment on U.S. breast cancer mortality rates, several parameters were common to all the Cancer Intervention and Surveillance Modeling Network (CISNET) models participating in the breast cancer base case. Models either used the parameters directly as input or calibrated their models to reproduce the common set of parameters. This chapter describes the common input parameters that are not specifically discussed elsewhere in the monograph.

Entities:  

Mesh:

Year:  2006        PMID: 17032891     DOI: 10.1093/jncimonographs/lgj005

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  24 in total

1.  Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.

Authors:  Sylvia K Plevritis; Diego Munoz; Allison W Kurian; Natasha K Stout; Oguzhan Alagoz; Aimee M Near; Sandra J Lee; Jeroen J van den Broek; Xuelin Huang; Clyde B Schechter; Brian L Sprague; Juhee Song; Harry J de Koning; Amy Trentham-Dietz; Nicolien T van Ravesteyn; Ronald Gangnon; Young Chandler; Yisheng Li; Cong Xu; Mehmet Ali Ergun; Hui Huang; Donald A Berry; Jeanne S Mandelblatt
Journal:  JAMA       Date:  2018-01-09       Impact factor: 56.272

2.  Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening.

Authors:  Amy Trentham-Dietz; Mehmet Ali Ergun; Oguzhan Alagoz; Natasha K Stout; Ronald E Gangnon; John M Hampton; Kim Dittus; Ted A James; Pamela M Vacek; Sally D Herschorn; Elizabeth S Burnside; Anna N A Tosteson; Donald L Weaver; Brian L Sprague
Journal:  Breast Cancer Res Treat       Date:  2017-11-28       Impact factor: 4.872

3.  Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis.

Authors:  Nataliya G Batina; Amy Trentham-Dietz; Ronald E Gangnon; Brian L Sprague; Marjorie A Rosenberg; Natasha K Stout; Dennis G Fryback; Oguzhan Alagoz
Journal:  Breast Cancer Res Treat       Date:  2013-02-16       Impact factor: 4.872

4.  Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.

Authors:  Diego Munoz; Aimee M Near; Nicolien T van Ravesteyn; Sandra J Lee; Clyde B Schechter; Oguzhan Alagoz; Donald A Berry; Elizabeth S Burnside; Yaojen Chang; Gary Chisholm; Harry J de Koning; Mehmet Ali Ergun; Eveline A M Heijnsdijk; Hui Huang; Natasha K Stout; Brian L Sprague; Amy Trentham-Dietz; Jeanne S Mandelblatt; Sylvia K Plevritis
Journal:  J Natl Cancer Inst       Date:  2014-09-24       Impact factor: 13.506

5.  The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.

Authors:  Ronald E Gangnon; Brian L Sprague; Natasha K Stout; Oguz Alagoz; Harald Weedon-Fekjær; Theodore R Holford; Amy Trentham-Dietz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-03-18       Impact factor: 4.254

6.  A Bayesian Simulation Model for Breast Cancer Screening, Incidence, Treatment, and Mortality.

Authors:  Xuelin Huang; Yisheng Li; Juhee Song; Donald A Berry
Journal:  Med Decis Making       Date:  2017-06-19       Impact factor: 2.583

7.  Structure, Function, and Applications of the Georgetown-Einstein (GE) Breast Cancer Simulation Model.

Authors:  Clyde B Schechter; Aimee M Near; Jinani Jayasekera; Young Chandler; Jeanne S Mandelblatt
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

8.  Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling.

Authors:  Jeanne S Mandelblatt; Aimee M Near; Diana L Miglioretti; Diego Munoz; Brian L Sprague; Amy Trentham-Dietz; Ronald Gangnon; Allison W Kurian; Harald Weedon-Fekjaer; Kathleen A Cronin; Sylvia K Plevritis
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

9.  The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update.

Authors:  Sandra J Lee; Xiaoxue Li; Hui Huang; Marvin Zelen
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

10.  Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia.

Authors:  Jeroen J van den Broek; Nicolien T van Ravesteyn; Eveline A Heijnsdijk; Harry J de Koning
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.